Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.
Rozenblit, M., Hendrickx, W., Heguy, A., Chiriboga, L., Loomis C., Ray, K., Darvishian, F., Egeblad M., Demaria, S., Marincola, F., Bedognetti, D., and Adams, S. (2019). Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. Sci Rep, 9(1), 8572. doi: 10.1038/s41598-019-42784-9.
